Drug therapy for benign prostatic hyperplasia and individualized drug regime / 药学实践杂志
Journal of Pharmaceutical Practice
;
(6): 447-448,456, 2017.
Artículo
en Chino
| WPRIM
| ID: wpr-790791
ABSTRACT
Objective To review the drug therapies for benign prostatic hyperplasia (BPH) and provide a reference for clinical individualized medication regime.Methods The mechanisms and clinical indications of commonly used BPH medications and some new drugs were discussed.The challenges for BPH therapies were also explored.Results α-receptor inhibitors and 5α-reductase inhibitors have the best effect for BPH.Surgery is needed for the BPH patients who are not responsive to the drug therapy.Conclusion Individualized medication programs reduce the medication waste and give patients the best treatment options.
Texto completo:
Disponible
Índice:
WPRIM (Pacífico Occidental)
Idioma:
Chino
Revista:
Journal of Pharmaceutical Practice
Año:
2017
Tipo del documento:
Artículo
Similares
MEDLINE
...
LILACS
LIS